Bacteria Keep Reminding Us: There Are No Silver Bullets
- 15 November 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (10), 2717-2718
- https://doi.org/10.1093/cid/ciaa361
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosaClinical Infectious Diseases, 2020
- Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyThe Lancet Infectious Diseases, 2020
- Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription DataOpen Forum Infectious Diseases, 2019
- Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialInfectious Diseases and Therapy, 2018
- Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant EnterobacteriaceaeClinical Infectious Diseases, 2017
- Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae BacteremiaAntimicrobial Agents and Chemotherapy, 2017